All Stories

Evotec axes 30% of assets as cost-cutting push hits pipeline

Evotec’s cost-cutting drive has reached its pipeline. The company axed around 30% of its asset portfolio and offloaded clinical program EVT 201 as part of a broader, ongoing attempt to correct its course.

Apr 17, 2025 - 14:50
 0
Evotec axes 30% of assets as cost-cutting push hits pipeline
Evotec’s cost-cutting drive has reached its pipeline. The company axed around 30% of its asset portfolio and offloaded clinical program EVT 201 as part of a broader, ongoing attempt to correct its course.
Read More

Tags:

Previous Article

Lyft Expands in Europe, Acquires FREENOW from BMW and Mercedes

Next Article

Big changes coming to federal health IT regulator?

Related Posts

Charles River lays off staffers at Memphis cell therapy manufacturing site

Charles River lays off staffers at Memphis cell therapy...

Feb 19, 2025  0

Fierce Biotech Fundraising Tracker '25: Attovia attracts $90M series C; Merida debuts with $121M

Fierce Biotech Fundraising Tracker '25: Attovia attract...

Apr 15, 2025  0

Mission changes, shuttering lab to focus on clinical assets

Mission changes, shuttering lab to focus on clinical as...

Feb 28, 2025  0